Bicara Therapeutics Inc…announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ﬁcerafusp alfa

ficerafusp alfa (BCA101) - Biocon

Oct 13, 2025